ILC1 drive intestinal epithelial and matrix remodelling
Source abstract
Abstract
Organoids can shed light on the dynamic interplay between complex tissues and rare cell types within a controlled microenvironment. Here, we develop gut organoid cocultures with type-1 innate lymphoid cells (ILC1) to dissect the impact of their accumulation in inflamed intestines. We demonstrate that murine and human ILC1 secrete transforming growth factor β1, driving expansion of CD44v6+ epithelial crypts. ILC1 additionally express MMP9 and drive gene signatures indicative of extracellular matrix remodelling. We therefore encapsulated human epithelial-mesenchymal intestinal organoids in MMP-sensitive, synthetic hydrogels designed to form efficient networks at low polymer concentrations. Harnessing this defined system, we demonstrate that ILC1 drive matrix softening and stiffening, which we suggest occurs through balanced matrix degradation and deposition. Our platform enabled us to elucidate previously undescribed interactions between ILC1 and their microenvironment, which suggest that they may exacerbate fibrosis and tumour growth when enriched in inflamed patient tissues.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: IL-33, ST2, and ILC Pathways · Eosinophilic Esophagitis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Haber, A. L. et al. A single-cell survey of the small intestinal epithelium. Nature 551, 333–339 (2017).10.1038/nature24489 ↗
2. Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054–1066 (2018).10.1016/j.cell.2018.07.017 ↗
3. Lindemans, C. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560 (2015).10.1038/nature16460 ↗
4. Spits, H., Bernink, J. H. & Lanier, L. NK cells and type 1 innate lymphoid cells: partners in host defense. Nat. Immunol. 17, 758–764 (2016).10.1038/ni.3482 ↗
5. Bernink, J. H. et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221–229 (2013).10.1038/ni.2534 ↗
6. Pagnini, C., Pizarro, T. T. & Cominelli, F. Novel pharmacological therapy in inflammatory bowel diseases: beyond anti-tumor necrosis factor. Front. Pharmacol. 10, 671 (2019).10.3389/fphar.2019.00671 ↗
7. Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415–418 (2011).10.1038/nature09637 ↗
8. Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109 (2011).10.1038/nature09691 ↗
9. Senbanjo, L. T. & Chellaiah, M. A. CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front. Cell Dev. Biol. 5, 18 (2017).10.3389/fcell.2017.00018 ↗
10. Martin-Gallausiaux, C. et al. Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells. Sci. Rep. 8, 9742 (2018).10.1038/s41598-018-28048-y ↗
11. Zeilstra, J. et al. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling. Oncogene 33, 665–670 (2014).10.1038/onc.2012.611 ↗
12. Ghatak, S. et al. Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. J. Biol. Chem. 292, 10465–10489 (2017).10.1074/jbc.M116.752451 ↗
13. Schmitt, M., Metzger, M., Gradl, D., Davidson, G. & Orian-Rousseau, V. CD44 functions in Wnt signaling by regulating LRP6 localization and activation. Cell Death Differ. 22, 677–689 (2015).10.1038/cdd.2014.156 ↗
14. Ribes, B. M. et al. Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis. Eur. J. Hosp. Pharm. https://doi.org/10.1136/ejhpharm-2018-001806 (2019).10.1136/ejhpharm-2018-001806 ↗
15. Yin, N. et al. p38γ MAPK is required for inflammation-associated colon tumorigenesis. Oncogene 35, 1039–1048 (2016).10.1038/onc.2015.158 ↗
16. Fujii, M. et al. Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell 23, 787–793.e6 (2018).10.1016/j.stem.2018.11.016 ↗
17. Dotti, I. et al. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. Gut 66, 2069–2079 (2017).10.1136/gutjnl-2016-312609 ↗
18. McCracken, K. W., Howell, J. C., Wells, J. M. & Spence, J. R. Generating human intestinal tissue from pluripotent stem cells in vitro. Nat. Protoc. 6, 1920–1928 (2011).10.1038/nprot.2011.410 ↗
19. Jung, K. B. et al. Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids. Nat. Commun. 9, 3039 (2018).10.1038/s41467-018-05450-8 ↗
20. Shimshoni, E., Yablecovitch, D., Baram, L., Dotan, I. & Sagi, I. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut 64, 367–372 (2015).10.1136/gutjnl-2014-308048 ↗
21. Farkas, K. et al. The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases. J. Crohn’s Colitis 9, 231–237 (2015).10.1093/ecco-jcc/jjv005 ↗
22. Hughes, C. S., Postovit, L. M. & Lajoie, G. A. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10, 1886–1890 (2010).10.1002/pmic.200900758 ↗
23. Ehrbar, M. et al. Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions. Biomacromolecules 8, 3000–3007 (2007).10.1021/bm070228f ↗
24. Zhong, M., Wang, R., Kawamoto, K., Olsen, B. D. & Johnson, J. A. Quantifying the impact of molecular defects on polymer network elasticity. Science 353, 1264–1268 (2016).10.1126/science.aag0184 ↗
25. Cruz-Acuña, R. et al. PEG-4MAL hydrogels for human organoid generation, culture, and in vivo delivery. Nat. Protoc. 13, 2102–2119 (2018).10.1038/s41596-018-0036-3 ↗
26. Gu, Y. et al. Semibatch monomer addition as a general method to tune and enhance the mechanics of polymer networks via loop-defect control. Proc. Natl Acad. Sci. USA 114, 4875–4880 (2017).10.1073/pnas.1620985114 ↗
27. Stewart, D. C. et al. Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. PLoS ONE 13, e0200377 (2018).10.1371/journal.pone.0200377 ↗
28. Schultz, K. M., Kyburz, K. A. & Anseth, K. S. Measuring dynamic cell–material interactions and remodeling during 3D human mesenchymal stem cell migration in hydrogels. Proc. Natl Acad. Sci. USA 112, E3757–E3764 (2015).
29. Hocevar, B. A., Brown, T. L. & Howe, P. H. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345–1356 (1999).10.1093/emboj/18.5.1345 ↗
30. Li, J., Wu, J., Zhang, M. & Zheng, Y. Dynamic changes of innate lymphoid cells in acute ST-segment elevation myocardial infarction and its association with clinical outcomes. Sci. Rep. 10, 5099 (2020).10.1038/s41598-020-61903-5 ↗
31. Bauché, D. & Marie, J. C. Transforming growth factor β: a master regulator of the gut microbiota and immune cell interactions. Clin. Transl. Immunol. 6, e136 (2017).10.1038/cti.2017.9 ↗
32. Fenton, T. M. et al. Inflammatory cues enhance TGFβ activation by distinct subsets of human intestinal dendritic cells via integrin αvβ8. Mucosal Immunol. 10, 624–634 (2017).10.1038/mi.2016.94 ↗
33. Bal, S. M., Golebski, K. & Spits, H. Plasticity of innate lymphoid cell subsets. Nat. Rev. Immunol. https://doi.org/10.1038/s41577-020-0282-9 (2020).10.1038/s41577-020-0282-9 ↗
34. Wang, J. et al. CD44v6 promotes β-catenin and TGF-β expression, inducing aggression in ovarian cancer cells. Mol. Med Rep. 11, 3505–3510 (2015).10.3892/mmr.2015.3145 ↗
35. Wang, Z., Zhao, K., Hackert, T. & Zöller, M. CD44/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression. Front. Cell Dev. Biol. 6, 97 (2018).10.3389/fcell.2018.00097 ↗
36. Ma, L., Dong, L. & Chang, P. CD44v6 engages in colorectal cancer progression. Cell Death Dis. 10, 30 (2019).10.1038/s41419-018-1265-7 ↗
37. Todaro, M. et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 14, 342–356 (2014).10.1016/j.stem.2014.01.009 ↗
38. de Bruyn, J. R. et al. Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn’s disease. PLoS ONE 13, e0190999 (2018).10.1371/journal.pone.0190999 ↗
39. Sato, T. & Clevers, H. Primary mouse small intestinal epithelial cell cultures. Methods Mol. Biol. 945, 319–328 (2013).10.1007/978-1-62703-125-7_19 ↗
40. Gronke, K., Kofoed-Nielsen, M. & Diefenbach, A. in Methods in Molecular Biology Vol. 1559 (eds Clausen, B. & Laman, J.) 255–265 (Humana, 2017).10.1007/978-1-4939-6786-5_17 ↗
41. Di Marco Barros, R. et al. Epithelia use butyrophilin-like molecules to shape organ-specific γδ T cell compartments. Cell 167, 203–218.e17 (2016).10.1016/j.cell.2016.08.030 ↗
42. Omer, O. S., Powell, N. & Lord, G. M. Characterizing innate lymphoid cell phenotype and function in human inflammatory bowel disease. In Innate Lymphoid Cells. Methods in Molecular Biology (ed. Amarnath, S.) Vol. 2121 (Humana, 2020).10.1007/978-1-0716-0338-3_17 ↗
43. de Jong, D. H. et al. Improved parameters for the Martini coarse-grained protein force field. J. Chem. Theory Comput. 9, 687–697 (2013).10.1021/ct300646g ↗
44. Lee, H., de Vries, A. H., Marrink, S. & Pastor, R. W. A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics. J. Phys. Chem. B 113, 13186–13194 (2009).10.1021/jp9058966 ↗
45. Martínez, L., Andrade, R., Birgin, E. G. & Martínez, J. M. PACKMOL: a package for building initial configurations for molecular dynamics simulations. J. Comput. Chem. 30, 2157–2164 (2009).10.1002/jcc.21224 ↗
46. Plimpton, S. Fast parallel algorithms for short-range molecular dynamics. J. Comput. Phys. 117, 1–19 (1995).10.1006/jcph.1995.1039 ↗
47. Bode, F. et al. Hybrid gelation processes in enzymatically gelled gelatin: impact on nanostructure, macroscopic properties and cellular response. Soft Matter 9, 6986–6999 (2013).10.1039/C3SM00125C ↗
48. Hutter, J. L. & Bechhoefer, J. Calibration of atomic‐force microscope tips. Rev. Sci. Instrum. 64, 1868–1873 (1993).10.1063/1.1143970 ↗
49. Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinform. 10, 161 (2009).10.1186/1471-2105-10-161 ↗
50. Carpenter, B. et al. Stan: a probabilistic programming language. J. Stat. Softw. 76, 1–32 (2017).10.18637/jss.v076.i01 ↗
51. Ferreira, S. A. et al. Bi-directional cell-pericellular matrix interactions direct stem cell fate. Nat. Commun. 9, 4049–12 (2018).10.1038/s41467-018-06183-4 ↗
52. Lochner, M. et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells. J. Exp. Med. 205, 1381–1393 (2008).10.1084/jem.20080034 ↗